Literature DB >> 17937291

Enantioselectivity in estrogenic potential and uptake of bifenthrin.

Lumei Wang1, Weiping Liu, Caixia Yang, Zhiyan Pan, Jianying Gan, Chao Xu, Meirong Zhao, Daniel Schlenk.   

Abstract

Despite the fact that the biological processes of chiral compounds are enantioselective, the endocrine disruption activity and uptake of chiral contaminants with respect to enantioselectivity has so far received limited research. In this study, the estrogenic potential and uptake of the enantiomers of a newer pyrethroid insecticide, bifenthrin (BF), were investigated. Significant differences in estrogenic potential were observed between the two enantiomers in the in vitro human breast carcinoma MCF-7 cell proliferation assay (i.e., the E-SCREEN assay) and the in vivo aquatic vertebrate vitellogenin enzyme-linked immunosorbent assay (ELISA). In the E-SCREEN assay, the relative proliferative effect ratios of 1S-cis-BF and 1R-cis-BF were 74.2% and 20.9%, respectively, and the relative proliferative potency ratios were 10% and 1%, respectively. The cell proliferation induced by the two BF enantiomers may be through the classical estrogen response pathway via the estrogen receptor (ER), as the proliferation induced by the enantiomers could be completely blocked when combined with 10-6 mol/L of the ER antagonist ICI 182,780. Measurement of vitellogenin induction in Japanese medaka (Oryzias latipes) showed that, at an exposure level of 10 ng/mL, the response to 1S-cis-BF was about 123 times greater than thattothe Renantiomer. Significant selectivity also occurred in the uptake of BF enantiomers in the liver and other tissues of J. medaka. These results together suggest that assessment of the environmental safety of chiral insecticides should consider enantioselectivity in acute and chronic ecotoxicities such as endocrine disruption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937291     DOI: 10.1021/es070220d

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  7 in total

1.  Estimation of soil-specific microbial degradation of alpha-cypermethrin by compound-specific stable isotope analysis.

Authors:  Shiwei Jin; Xiaoshan Yao; Zemin Xu; Xichang Zhang; Fangxing Yang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-31       Impact factor: 4.223

2.  The in vivo estrogenic and in vitro anti-estrogenic activity of permethrin and bifenthrin.

Authors:  Susanne M Brander; Guochun He; Kelly L Smalling; Michael S Denison; Gary N Cherr
Journal:  Environ Toxicol Chem       Date:  2012-10-24       Impact factor: 3.742

3.  Effects of salinity acclimation on the endocrine disruption and acute toxicity of bifenthrin in freshwater and euryhaline strains of Oncorhynchus mykiss.

Authors:  Navneet Riar; Jordan Crago; Weiying Jiang; Lindley A Maryoung; Jay Gan; Daniel Schlenk
Journal:  Environ Toxicol Chem       Date:  2013-10-18       Impact factor: 3.742

4.  Evaluation of the estrogen receptor alpha as a possible target of bifenthrin effects in the estrogenic and dopaminergic signaling pathways in zebrafish embryos.

Authors:  Luísa Becker Bertotto; Subham Dasgupta; Sara Vliet; Stacia Dudley; Jay Gan; David C Volz; Daniel Schlenk
Journal:  Sci Total Environ       Date:  2018-10-09       Impact factor: 7.963

5.  Microbial detoxification of bifenthrin by a novel yeast and its potential for contaminated soils treatment.

Authors:  Shaohua Chen; Jianjun Luo; Meiying Hu; Peng Geng; Yanbo Zhang
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

6.  Gas Chromatography Residue Analysis of Bifenthrin in Pears Treated with 2% Wettable Powder.

Authors:  Jeong-Heui Choi; Xue Liu; Hee-Kwon Kim; Jae-Han Shim
Journal:  Toxicol Res       Date:  2009-03-01

7.  Transcriptomic and Histopathological Effects of Bifenthrin to the Brain of Juvenile Rainbow Trout (Oncorhynchus mykiss).

Authors:  Jason T Magnuson; Kara E Huff Hartz; Corie A Fulton; Michael J Lydy; Daniel Schlenk
Journal:  Toxics       Date:  2021-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.